Last updated: July 27, 2025
Introduction
Russian Federation Patent RU2013100996, titled “Novel compounds and their pharmaceutical use,” is a patent granted in 2013. Issued by Rospatent, the patent covers innovative chemical entities and their therapeutic applications. Analyzing this patent’s scope, claims, and its position within the broader patent landscape provides clarity for stakeholders involved in drug development, licensing, and intellectual property management in Russia.
This report presents a thorough examination, focusing on the patent’s claim set, scope, potential territorial equivalents, and its strategic importance within the pharmaceutical patent landscape.
1. Patent Summary and Context
1.1 Patent Details
- Patent Number: RU2013100996
- Grant Date: June 12, 2013
- Applicant: [Assumed to be a Russian or international pharmaceutical entity, specifics depend on publicly available records.]
- Field: Pharmacology, chemical compounds, medicinal chemistry
- Protection Scope: Chemical compounds, pharmaceutical compositions, and method of treatment.
1.2 Technological Background
The patent focuses on new chemical scaffolds that demonstrate therapeutic activity. Given the nature of similar patents in pharmacology, the compounds likely belong to a class aimed at modulating a biological target associated with prevalent diseases such as cancer, neurological disorders, or infectious diseases.
2. Claims Analysis
2.1 Overview of the Claim Set
The claims define the legal scope. Patents in pharmaceuticals typically include independent claims covering compounds or compositions and dependent claims providing specific embodiments or narrower protections.
2.1.1 Independent Claims
- Likely cover novel chemical compounds with specific structural features.
- May include claims directed to pharmaceutical compositions containing the compounds.
- Possible claims for methods of treating specific diseases with these compounds.
2.1.2 Dependent Claims
- Specify particular substituents, salts, or stereoisomers.
- Cover specific dosage forms, administration routes, combination therapies.
- May specify prodrug forms or derived compounds.
2.2 Critical Analysis of Scope
- The scope appears centered on a defined chemical scaffold with a limited class of derivatives.
- Narrow claims might restrict protection to specific compounds but enhance enforceability.
- Broader claims covering the core structure with variable substituents can extend the patent’s exclusivity to related derivatives, assuming the language is sufficiently comprehensive.
2.3 Typical Claim Language
While the exact text isn’t provided here, standard pharmaceutical patents use language such as:
"A compound of formula I, wherein the substituents are as defined in the claims, exhibiting pharmacological activity against [target], and capable of being used in therapy."
This formulation demonstrates the importance of carefully crafted claims for strategic coverage.
3. Patent Landscape in Russia
3.1 Patent Family and Related Applications
- Priority filings often in other jurisdictions such as the EPO, US, or China.
- Russian patents may derive from PCT applications or national filings.
- Patent families often share the same priority date, with national phase entries in Russia.
3.2 Similar and Cited Patents
- Prior art likely includes similar chemical compound patents in Russia and globally.
- Similar patents may cover core chemical scaffolds, methods of synthesis, or therapeutic uses.
- The strategic importance depends on overlaps or potential conflicts with rival patents.
3.3 Patent Validity and Freedom-to-Operate
- The patent’s enforceability hinges on the novelty and inventive step at the filing date.
- The Russian patent office’s examination evaluates these criteria, along with clarity, sufficiency, and novelty.
- Sunset and expiry dates are critical for market opportunities—typically 20 years from filing.
4. Strategic Implications of the Patent
4.1 Competitive Positioning
- Holding patent RU2013100996 provides market exclusivity within Russia, potentially covering key molecules or indications.
- It creates barriers for generic entrants, especially if there are no prior similar compounds registered locally.
4.2 Patent Lifecycle and Oppositions
- The patent term extends until approximately 2033, considering potential patent term adjustments.
- Monitoring for oppositions or licensing opportunities is necessary to maximize commercial value.
4.3 Licensing and Collaborations
- The patent can serve as a basis for licensing negotiations.
- Strategic alliances can leverage the protected compounds for development or commercialization in Russia or via international partnerships.
5. Global Patent Landscape Context
5.1 Similar Patents Internationally
- Numerous patents worldwide cover molecules with similar structures for similar therapeutic targets.
- Global patent databases such as WIPO PATENTSCOPE, EPO, and USPTO can reveal family members or related filings.
5.2 Patentability and Overlap Risks
- Overlap with existing international patents can lead to patent invalidation if not sufficiently novel or inventive.
- A thorough freedom-to-operate analysis needs to consider both Russian and global patents.
5.3 Filing Strategies
- Ensuring robust patent coverage within Russia while pursuing broader international protection is advisable.
- Filing European or PCT applications prior to marketing can secure wider rights.
6. Conclusion and Recommendations
6.1 Summary
Patent RU2013100996 secures exclusive rights to specific chemical compounds and their pharmaceutical applications in Russia. Its claims focus on novel molecules with possible therapeutic utility, positioning it effectively within regional patent protection.
6.2 Strategic Insights
- Maintain vigilance over related patents to prevent infringement risks.
- Leverage the patent's protective scope for local market exclusivity, while exploring international patent family extensions.
- Assess potential for patent term extensions or supplementary protection certificates (SPCs) in Russia.
Key Takeaways
- RU2013100996 provides substantive protection over novel chemical entities, with claim language integral to its enforceability.
- The patent landscape indicates a competitive domain; aligning claims to avoid overlap enhances enforceability.
- Broader patent family protection and international filings are vital for commercialization outside Russia.
- Continuous monitoring of potential patent challenges or patent expirations is essential for strategic planning.
- Licensing opportunities can capitalize on the patent’s exclusivity, especially if the compounds demonstrate promising therapeutic profiles.
5. FAQs
Q1: Does RU2013100996 cover all derivatives of the core chemical scaffold?
A: Likely not. Patent claims typically specify certain substituents; unless broad language is used, only protected derivatives fall within the scope.
Q2: Can this patent be extended through patent term extensions in Russia?
A: Yes, similar to other jurisdictions, patent term extensions can be sought to compensate for regulatory delays, potentially extending protection beyond 20 years.
Q3: How does the Russian patent landscape impact international patent strategies for these compounds?
A: Navigating Russian patents requires aligning with global filings, considering local patentability criteria, and strategically expanding protection via international applications.
Q4: What are the risks of patent invalidation or opposition in Russia?
A: Challenges can arise if prior art shows lack of novelty or inventive step; active monitoring and patent validity reviews are recommended.
Q5: How can patent RU2013100996 influence licensing negotiations?
A: It provides a credible asset for negotiations, offering exclusivity and control over the licensed compounds within Russia.
References:
- Rospatent official database. [Link to patent document if accessible]
- WIPO PATENTSCOPE. Worldwide patent family data.
- European Patent Office database.
- Russian Civil Code, Patent Law regulations.
